These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 15606670)
21. S100A6 protein expression is different in Spitz nevi and melanomas. Ribé A; McNutt NS Mod Pathol; 2003 May; 16(5):505-11. PubMed ID: 12748257 [TBL] [Abstract][Full Text] [Related]
22. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours. Miracco C; De Nisi MC; Arcuri F; Cosci E; Pacenti L; Toscano M; Lalinga AV; Biagioli M; Rubegni P; Vatti R; Maellaro E; Del Bello B; Massi D; Luzi P; Tosi P Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788 [TBL] [Abstract][Full Text] [Related]
23. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions. Wang H; Shen SS; Wang H; Diwan AH; Zhang W; Fuller GN; Prieto VG J Cutan Pathol; 2003 Nov; 30(10):599-605. PubMed ID: 14744083 [TBL] [Abstract][Full Text] [Related]
25. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions. Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395 [TBL] [Abstract][Full Text] [Related]
26. Fascin, cortactin and survivin expression of melanocytic neoplasms and association with clinicopathological parameters and anatomic locations in Chinese people. Gao HW; Yu CP; Lee HS; Nieh S; Chiang CP; Wang WM; Jin JS Eur J Dermatol; 2010; 20(3):293-301. PubMed ID: 20400386 [TBL] [Abstract][Full Text] [Related]
27. IMP-3 is a novel progression marker in malignant melanoma. Pryor JG; Bourne PA; Yang Q; Spaulding BO; Scott GA; Xu H Mod Pathol; 2008 Apr; 21(4):431-7. PubMed ID: 18204432 [TBL] [Abstract][Full Text] [Related]
28. Expression of SOX10, ABCB5 and CD271 in melanocytic lesions and correlation with survival data of patients with melanoma. Gambichler T; Petig AL; Stockfleth E; Stücker M Clin Exp Dermatol; 2016 Oct; 41(7):709-16. PubMed ID: 27663144 [TBL] [Abstract][Full Text] [Related]
29. CD31 and CD34 expression as immunohistochemical markers of endothelial transdifferentiation in human cutaneous melanoma. Pisacane AM; Picciotto F; Risio M Cell Oncol; 2007; 29(1):59-66. PubMed ID: 17429142 [TBL] [Abstract][Full Text] [Related]
30. Fibroblast activation protein: differential expression and serine protease activity in reactive stromal fibroblasts of melanocytic skin tumors. Huber MA; Kraut N; Park JE; Schubert RD; Rettig WJ; Peter RU; Garin-Chesa P J Invest Dermatol; 2003 Feb; 120(2):182-8. PubMed ID: 12542520 [TBL] [Abstract][Full Text] [Related]
31. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses. Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460 [TBL] [Abstract][Full Text] [Related]
33. Differential expression of basic fibroblast growth factor (bFGF) in melanocytic lesions demonstrated by in situ hybridization. Implications for tumor progression. Reed JA; McNutt NS; Albino AP Am J Pathol; 1994 Feb; 144(2):329-36. PubMed ID: 8311116 [TBL] [Abstract][Full Text] [Related]
34. Differential expression of heat shock protein 105 in melanoma and melanocytic naevi. Muchemwa FC; Nakatsura T; Fukushima S; Nishimura Y; Kageshita T; Ihn H Melanoma Res; 2008 Jun; 18(3):166-71. PubMed ID: 18477890 [TBL] [Abstract][Full Text] [Related]
35. Expression of the mast cell growth factor interleukin-3 in melanocytic lesions correlates with an increased number of mast cells in the perilesional stroma: implications for melanoma progression. Reed JA; McNutt NS; Bogdany JK; Albino AP J Cutan Pathol; 1996 Dec; 23(6):495-505. PubMed ID: 9001979 [TBL] [Abstract][Full Text] [Related]
36. CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin. Wessel C; Westhoff CC; Nowak K; Moll I; Barth PJ Virchows Arch; 2008 Nov; 453(5):485-9. PubMed ID: 18813945 [TBL] [Abstract][Full Text] [Related]
37. Proliferative Nodules vs Melanoma Arising in Giant Congenital Melanocytic Nevi During Childhood. Vergier B; Laharanne E; Prochazkova-Carlotti M; de la Fouchardière A; Merlio JP; Kadlub N; Avril MF; Bodemer C; Lacoste C; Boralevi F; Taieb A; Ezzedine K; Fraitag S JAMA Dermatol; 2016 Oct; 152(10):1147-1151. PubMed ID: 27486690 [TBL] [Abstract][Full Text] [Related]
38. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions. Nasr MR; El-Zammar O Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113 [TBL] [Abstract][Full Text] [Related]
39. Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions. Ivan D; Diwan AH; Esteva FJ; Prieto VG Mod Pathol; 2004 Jul; 17(7):811-8. PubMed ID: 15154004 [TBL] [Abstract][Full Text] [Related]
40. Melanoma-associated expression of transforming growth factor-beta isoforms. Van Belle P; Rodeck U; Nuamah I; Halpern AC; Elder DE Am J Pathol; 1996 Jun; 148(6):1887-94. PubMed ID: 8669474 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]